propranolol has been researched along with esmolol in 51 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (19.61) | 18.7374 |
1990's | 8 (15.69) | 18.2507 |
2000's | 14 (27.45) | 29.6817 |
2010's | 17 (33.33) | 24.3611 |
2020's | 2 (3.92) | 2.80 |
Authors | Studies |
---|---|
Anderson, WG; Erhardt, PW; Gorczynski, RJ; Woo, CM | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Chang, Q; Chen, Z; Hu, G; Hu, L; Li, Q; Long, J | 1 |
Brunette, DD; Rothong, C | 1 |
Hirshman, CA; Sauder, RA; Tobias, JD | 1 |
Carpenter, RL; Guinard, JP; Knopes, KD; Mulroy, MF | 1 |
Hakki, AH; Iskandrian, AS; Laddu, A | 1 |
Anderson, J; Horowitz, LN; Morganroth, J; Turlapaty, P | 1 |
Koshakji, RP; Reilly, CS; Wood, AJ; Wood, M | 1 |
Bell, V; Byrd, RC; DiStefano, S; Eschenbacher, WL; Laddu, A; Sheppard, D; Steck, J | 1 |
Blanski, L; Kirshenbaum, J; Laddu, AR; MacCosbe, P; Sung, RJ; Turlapaty, P | 1 |
Gorczynski, RJ; Quon, CY | 1 |
Littman, WJ; Pope, C; Scanlon, PJ; Wallis, DE | 1 |
Abrams, J; Allen, J; Allin, D; Anderson, J; Anderson, S; Blanski, L; Chadda, K; DiBianco, R; Favrot, L; Gonzalez, J | 1 |
Hakki, AH; Iskandrian, AS; Kane-Marsch, S; Laddu, A; Morganroth, J; Saunders, R; Steck, J | 1 |
Hepp, H; Klocke, G; Knitza, R; Riesselmann, A; Wisser, J | 1 |
Deegan, R; Wood, AJ | 1 |
Coddington, CC; McCurdy, CM; Rutherford, SE | 1 |
Hagihara, A; Hashimoto, K; Motomura, S; Narumi, Y | 1 |
Buheitel, G; Hofbeck, M; Leipold, G; Singer, H | 1 |
Bailey, WE; Kosar, EM; Nademanee, K; Rieders, DE; Taylor, R | 1 |
Hou, Y; Jackman, WM; Lazzara, R; Schauerte, P; Scherlag, BJ; Scherlag, M; Sun, YX; Yamanashi, WS | 1 |
Fujita, S; Kanaya, N; Kurosawa, S; Nakayama, M; Namiki, A; Niiyama, Y | 1 |
Andersson, KK; Barra, AL; Engalytcheff, A; Kolberg, M; Tilquin, B | 1 |
Asada, A; Mizutani, K; Nakamura, C; Tsuchiya, M | 1 |
Gupta, R; Mahajan, R; Sharma, A | 1 |
Goyagi, T; Kimura, T; Masaki, Y; Nishikawa, T; Tobe, Y | 1 |
Bostan, H; Erciyes, N; Eroglu, A; Erturk, E; Geze, S; Saracoglu, S | 1 |
Kapoor, JR | 1 |
Buszewski, B; Krzemiński, TF; Tegowska, E; Welerowicz, T | 1 |
Aziz, PF; Pass, RH; Shah, MJ; Tanel, RE; Vetter, VL; Vogel, RL; Wieand, TS; Zelster, IJ | 1 |
Mizogami, M; Takakura, K; Tsuchiya, H | 1 |
Burman, KD; Carroll, NM; Devdhar, M; Popoveniuc, G; Sharma, M; Wartofsky, L; Wexler, JA | 1 |
Rudiger, A | 1 |
de Oliveira, FC; Feitosa-Filho, GS; Ritt, LE | 1 |
Guo, Q; Wang, L; Yang, G; Yang, J | 1 |
Anderson, WJ; Lipworth, BJ; Short, PM; Williamson, PA | 1 |
Akdeniz, C; Ergül, Y; Özyılmaz, İ; Saygı, M; Tola, HT; Tuzcu, V | 1 |
Freissmuth, M; Nanoff, C; Nasrollahi-Shirazi, S; Sucic, S; Yang, Q | 1 |
Gardiner, M; Kienstra, AJ; Ruttan, TK; Wilkinson, M | 1 |
Brubaker, S; Koyfman, A; Long, B | 1 |
Cafferkey, A; McMahon, C | 1 |
Addison, D; Alam, M; Jneid, H; Kayani, W; Lakkis, N; Misra, A; Pham, D; Resar, J | 1 |
Chang, YT; Cheng, CC; Huang, MS; Huang, NC; Huang, WC; Hung, YM; Ke, MW; Tsai, JS; Wann, SR | 1 |
Chen, C; Ding, W; Du, Y; Ma, X; Sun, X; Tao, Y | 1 |
5 review(s) available for propranolol and esmolol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Beta-block the septic heart.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Disease Models, Animal; Heart; Humans; Propanolamines; Propranolol; Rats; Sepsis; Systemic Inflammatory Response Syndrome | 2010 |
Use of beta-blockers for the treatment of cardiac arrest due to ventricular fibrillation/pulseless ventricular tachycardia: a systematic review.
Topics: Adrenergic beta-Antagonists; Animals; Cardiopulmonary Resuscitation; Coronary Circulation; Epinephrine; Heart Arrest; Humans; Myocardium; Oxygen Consumption; Propanolamines; Propranolol; Tachycardia, Ventricular; Vasoconstrictor Agents; Vasopressins; Ventricular Fibrillation | 2012 |
Alternative Treatment Options for Atrioventricular-Nodal-Reentry Tachycardia: An Emergency Medicine Review.
Topics: Adenosine; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Calcium Channel Blockers; Diltiazem; Electric Countershock; Electrocardiography; Emergency Medicine; Emergency Service, Hospital; Female; Humans; Male; Metoprolol; Propanolamines; Propranolol; Review Literature as Topic; Tachycardia, Atrioventricular Nodal Reentry; Vagus Nerve Stimulation; Verapamil | 2018 |
Outcomes of beta blocker use in cocaine-associated chest pain: a meta-analysis.
Topics: Acute Coronary Syndrome; Adrenergic beta-Antagonists; Atenolol; Bisoprolol; Carvedilol; Cocaine; Humans; Metoprolol; Propanolamines; Propranolol | 2018 |
11 trial(s) available for propranolol and esmolol
Article | Year |
---|---|
Test doses: optimal epinephrine content with and without acute beta-adrenergic blockade.
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Epidural; Double-Blind Method; Epinephrine; Female; Heart Rate; Humans; Male; Propanolamines; Propranolol; Randomized Controlled Trials as Topic | 1990 |
Effects of esmolol on cardiac function: evaluation by noninvasive techniques.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Clinical Trials as Topic; Double-Blind Method; Exercise Test; Female; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Propanolamines; Propranolol; Radionuclide Imaging; Random Allocation | 1985 |
Comparative efficacy and tolerance of esmolol to propranolol for control of supraventricular tachyarrhythmia.
Topics: Adrenergic beta-Antagonists; Aged; Atrioventricular Node; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Female; Heart Ventricles; Humans; Infusions, Parenteral; Male; Middle Aged; Propanolamines; Propranolol; Random Allocation; Tachycardia | 1985 |
Effects of esmolol on airway function in patients with asthma.
Topics: Adrenergic beta-Antagonists; Adult; Airway Resistance; Asthma; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Forced Expiratory Volume; Heart Rate; Humans; Male; Placebos; Propanolamines; Propranolol; Pulse; Random Allocation; Vital Capacity | 1986 |
Clinical experience with esmolol, a short-acting beta-adrenergic blocker in cardiac arrhythmias and myocardial ischemia.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Double-Blind Method; Female; Heart Rate; Humans; Male; Middle Aged; Propanolamines; Propranolol; Random Allocation; Time Factors | 1986 |
Safety and efficacy of esmolol for unstable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Angina Pectoris; Angina, Unstable; Blood Pressure; Female; Heart Rate; Humans; Infusions, Intravenous; Male; Middle Aged; Pilot Projects; Propanolamines; Propranolol; Random Allocation | 1988 |
Efficacy and safety of esmolol vs propranolol in the treatment of supraventricular tachyarrhythmias: a multicenter double-blind clinical trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Female; Heart Rate; Humans; Male; Propanolamines; Propranolol; Tachycardia; Time Factors | 1985 |
Effects of intravenous infusion of esmolol and propranolol on biventricular performance at rest and during exercise as assessed by quantitative radionuclide angiography.
Topics: Aged; Blood Pressure; Double-Blind Method; Exercise Test; Female; Heart; Heart Rate; Hemodynamics; Humans; Infusions, Parenteral; Male; Middle Aged; Propanolamines; Propranolol; Radionuclide Imaging; Random Allocation; Rest; Stroke Volume; Time Factors | 1985 |
Beta-receptor antagonism does not fully explain esmolol-induced hypotension.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Blood Pressure; Dose-Response Relationship, Drug; Exercise; Humans; Infusions, Intravenous; Male; Metoprolol; Norepinephrine; Propanolamines; Propranolol | 1994 |
Treating electrical storm : sympathetic blockade versus advanced cardiac life support-guided therapy.
Topics: Adrenergic beta-Antagonists; Aged; Anti-Arrhythmia Agents; Autonomic Nerve Block; Female; Follow-Up Studies; Humans; Incidence; Life Support Care; Male; Middle Aged; Propanolamines; Propranolol; Prospective Studies; Recurrence; Stellate Ganglion; Time Factors; Ventricular Fibrillation | 2000 |
Effects of intravenous and oral β-blockade in persistent asthmatics controlled on inhaled corticosteroids.
Topics: Administration, Inhalation; Administration, Oral; Adrenergic beta-Antagonists; Adult; Aged; Airway Resistance; Asthma; Bronchodilator Agents; Dose-Response Relationship, Drug; Double-Blind Method; Female; Forced Expiratory Volume; Glucocorticoids; Humans; Injections, Intravenous; Male; Middle Aged; Propanolamines; Propranolol; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Young Adult | 2014 |
35 other study(ies) available for propranolol and esmolol
Article | Year |
---|---|
Ultra-short-acting beta-adrenergic receptor blocking agents. 2. (Aryloxy)propanolamines containing esters on the aryl function.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Dogs; Guinea Pigs; In Vitro Techniques; Muscle, Smooth; Muscle, Smooth, Vascular; Propanolamines; Structure-Activity Relationship; Time Factors | 1982 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Drug repurposing and rediscovery: Design, synthesis and preliminary biological evaluation of 1-arylamino-3-aryloxypropan-2-ols as anti-melanoma agents.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Drug Discovery; Drug Repositioning; Drug Screening Assays, Antitumor; Humans; Melanoma; Molecular Docking Simulation; Molecular Structure; Propanols; Skin Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2020 |
Emergency department management of thyrotoxic crisis with esmolol.
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Emergency Service, Hospital; Female; Humans; Propanolamines; Propranolol; Thyroid Crisis | 1991 |
Pulmonary reactivity to methacholine during beta-adrenergic blockade: propranolol versus esmolol.
Topics: Adrenergic beta-Antagonists; Anesthesia, General; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Drug Interactions; Fentanyl; Heart Rate; Isoproterenol; Lung; Methacholine Chloride; Methacholine Compounds; Propanolamines; Propranolol; Thiopental | 1990 |
Ultra-short-acting beta-blockade: a comparison with conventional beta-blockade.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Humans; Male; Propanolamines; Propranolol | 1985 |
Pharmacodynamics and onset of action of esmolol in anesthetized dogs.
Topics: Adrenergic beta-Antagonists; Anesthesia; Animals; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Male; Metabolic Clearance Rate; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Time Factors | 1986 |
[Therapy of fetal supraventricular tachycardia with esmolol (case report)].
Topics: Adrenergic beta-Antagonists; Adult; Drug Therapy, Combination; Female; Heart Rate, Fetal; Heart Septal Defects, Atrial; Humans; Infant, Newborn; Male; Pregnancy; Propanolamines; Propranolol; Tachycardia, Supraventricular | 1993 |
Syncope and sudden arrhythmic death complicating pregnancy. A case report of Romano-Ward syndrome.
Topics: Adrenergic beta-Antagonists; Adult; Bradycardia; Cesarean Section; Death, Sudden, Cardiac; Electric Countershock; Electrocardiography; Female; Fetal Diseases; Heart Rate; Heart Rate, Fetal; Humans; Long QT Syndrome; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Propanolamines; Propranolol; Syncope; Tachycardia, Ventricular | 1993 |
Time course of a new ultrashort-acting beta-adrenoceptor-blocking drug, ONO-1101: comparison with those of esmolol and propranolol by using the canine isolated, blood-perfused heart preparations.
Topics: Adrenergic beta-Antagonists; Animals; Blood; Dogs; Female; Heart; Hemodynamics; In Vitro Techniques; Male; Morpholines; Myocardial Contraction; Perfusion; Propanolamines; Propranolol; Sinoatrial Node; Urea | 1998 |
[Incidence and treatment of reactive infundibular obstruction after balloon dilatation of critical pulmonary valve stenoses].
Topics: Angiography; Catheterization; Echocardiography; Female; Follow-Up Studies; Heart Defects, Congenital; Humans; Infant; Infant, Newborn; Infusions, Intravenous; Male; Propanolamines; Propranolol; Pulmonary Subvalvular Stenosis; Pulmonary Valve Stenosis | 1999 |
Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation.
Topics: Acute Disease; Adrenergic beta-Antagonists; Animals; Atrial Fibrillation; Atropine; Autonomic Nervous System; Disease Models, Animal; Dogs; Electric Stimulation; Electrocardiography; Endothelium, Vascular; Heart Rate; Muscarinic Antagonists; Propanolamines; Propranolol; Pulmonary Artery | 2002 |
Landiolol, esmolol and propranolol protect from ischemia/reperfusion injury in isolated guinea pig hearts.
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Heart; In Vitro Techniques; Male; Morpholines; Myocardial Reperfusion Injury; Propanolamines; Propranolol; Time Factors; Urea; Ventricular Function, Left | 2003 |
The use of multi-frequency EPR techniques to identify the radicals produced in irradiated beta-blockers.
Topics: Adrenergic beta-Antagonists; Atenolol; Electron Spin Resonance Spectroscopy; Free Radicals; Nadolol; Propanolamines; Propranolol; Temperature | 2004 |
[A comparison of propranolol with esmolol for the treatment of tachycardia during emergence from anesthesia].
Topics: Adrenergic beta-Antagonists; Aged; Anesthesia, General; Emergencies; Female; Humans; Male; Middle Aged; Propanolamines; Propranolol; Retrospective Studies; Tachycardia | 2005 |
Management of serotonin syndrome.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Nitroprusside; Prognosis; Propanolamines; Propranolol; Risk Assessment; Serotonin Syndrome; Severity of Illness Index; Treatment Outcome | 2005 |
Beta-adrenoreceptor antagonists attenuate brain injury after transient focal ischemia in rats.
Topics: Adrenergic beta-Antagonists; Anesthesia; Anesthetics, Inhalation; Animals; Brain; Carbazoles; Carvedilol; Halothane; Ischemic Attack, Transient; Male; Morpholines; Myocardial Infarction; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Tetrazolium Salts; Urea | 2006 |
Total intravenous anesthesia for evacuation of a hydatidiform mole and termination of pregnancy in a patient with thyrotoxicosis.
Topics: Abortion, Induced; Adrenergic beta-Antagonists; Adult; Anesthesia, Intravenous; Anesthetics, Intravenous; Antihypertensive Agents; Antithyroid Agents; Female; Follow-Up Studies; Humans; Hydatidiform Mole; Methimazole; Piperidines; Pregnancy; Pregnancy Complications, Neoplastic; Propanolamines; Propofol; Propranolol; Remifentanil; Thyroid Function Tests; Thyrotoxicosis; Uterine Neoplasms | 2007 |
Predicting the effectiveness of beta-blocker therapy in vasovagal syncope.
Topics: Adrenergic beta-Antagonists; Humans; Propanolamines; Propranolol; Syncope, Vasovagal; Tilt-Table Test | 2008 |
Determination of selected beta-receptor antagonists in biological samples by solid-phase extraction with cholesterolic phase and LC/MS.
Topics: Acebutolol; Animals; Cholesterol; Chromatography, High Pressure Liquid; Humans; Male; Mice; Nadolol; Oxprenolol; Propanolamines; Propranolol; Reproducibility of Results; Silicon Dioxide; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Surface Properties | 2009 |
Congenital long QT syndrome and 2:1 atrioventricular block: an optimistic outcome in the current era.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atrioventricular Block; Child; Child, Preschool; Cohort Studies; Defibrillators, Implantable; Female; Flecainide; Genotype; Humans; Infant; Infant, Newborn; Long QT Syndrome; Male; Mexiletine; Multivariate Analysis; Prognosis; Propanolamines; Propranolol; Retrospective Studies; Risk Assessment; Risk Factors; Torsades de Pointes; Treatment Outcome | 2010 |
The interactivities with lipid membranes differentially characterize selective and nonselective beta1-blockers.
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia; Anesthetics; Atenolol; Biomimetics; Lipid Bilayers; Lipids; Liposomes; Membranes, Artificial; Metoprolol; Oxprenolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta | 2010 |
Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function.
Topics: Adrenergic beta-Antagonists; Adult; Anti-Inflammatory Agents; Antithyroid Agents; Calcium Channel Blockers; Diltiazem; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Organ Size; Prednisone; Propanolamines; Propranolol; Radiography; Thymus Gland; Thymus Hyperplasia; Thyroidectomy; Thyrotoxicosis; Thyrotropin; Thyroxine; Treatment Outcome; Triiodothyronine; Young Adult | 2010 |
[Chiral separation of five beta-blockers using di-n-hexyl L-tartrate-boric acid complex as mobile phase additive by reversed-phase liquid chromatography].
Topics: Adrenergic beta-Antagonists; Boric Acids; Chromatography, Reverse-Phase; Dicarboxylic Acids; Metoprolol; Propanolamines; Propranolol; Stereoisomerism; Sugar Acids | 2012 |
The use of flecainide in critical neonates and infants with incessant supraventricular tachycardias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Catheter Ablation; Drug Therapy, Combination; Female; Flecainide; Follow-Up Studies; Humans; Infant; Infant, Newborn; Male; Propanolamines; Propranolol; Retrospective Studies; Tachycardia, Supraventricular; Treatment Outcome | 2015 |
Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Blood Pressure; Cyclic AMP; Drug Partial Agonism; Heart Rate; HEK293 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Morpholines; Phosphorylation; Propanolamines; Propranolol; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Urea | 2016 |
Making the Quick Diagnosis: A Case of Neonatal Shock.
Topics: Acidosis; Acyclovir; Adenosine; Ampicillin; Anti-Arrhythmia Agents; Anti-Bacterial Agents; Antiviral Agents; Cardiomyopathies; Cefotaxime; Electrocardiography; Emergency Service, Hospital; Feeding Behavior; Fluid Therapy; Glucose; Humans; Hypoglycemia; Hypotension; Hypoxia; Infant, Newborn; Lethargy; Male; Propanolamines; Propranolol; Shock; Tachycardia; Tachycardia, Supraventricular; Vomiting; Wolff-Parkinson-White Syndrome | 2017 |
Successful Treatment of Refractory Cardiac Arrest With β-Blockade and Extracorporeal Life Support in a Pediatric Patient With Catecholaminergic Polymorphic Ventricular Tachycardia: A Case Report.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Atenolol; Calcium-Binding Proteins; Child; Combined Modality Therapy; Defibrillators, Implantable; Electrocardiography; Extracorporeal Membrane Oxygenation; Heart Arrest; Humans; Male; Membrane Proteins; Muscle Proteins; Mutation; Propanolamines; Propranolol; Sympathectomy; Tachycardia, Ventricular | 2018 |
Effects of epinephrine on heart rate variability and cytokines in a rat sepsis model.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-1 Receptor Antagonists; Animals; Cytokines; Disease Models, Animal; Epinephrine; Heart Rate; Male; Propanolamines; Propranolol; Rats; Rats, Sprague-Dawley; Sepsis | 2020 |
Metal organic framework HKUST-1 modified with carboxymethyl-β-cyclodextrin for use in improved open tubular capillary electrochromatographic enantioseparation of five basic drugs.
Topics: Amlodipine; beta-Cyclodextrins; Capillary Electrochromatography; Metal-Organic Frameworks; Metoprolol; Propanolamines; Propranolol; Sotalol; Stereoisomerism | 2019 |